LOUISE BYRNES: Open Payments
NPI 1679047294 · COATESVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,694 in 50 payments from 11 companies in 2025. Trend: 2023 $1,034 · 2024 $1,260 · 2025 $1,694
Food & beverage: $1,688Education: $7
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $695 |
| Vanda Pharmaceuticals Inc. | 7 | $342 |
| Axsome Therapeutics, Inc. | 7 | $151 |
| ABBVIE INC. | 9 | $139 |
| Neurocrine BioSciences, Inc. | 4 | $114 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Almatica Pharma LLC | 1 | $25 |
Products named: CAPLYTA, FANAPT, Auvelity, VRAYLAR, INGREZZA, REXULTI, Quviviq, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
